Because E9 cells are already transformed and do not require a progression phase for tumor growth and because alveolar macrophages differ in function and response from macrophages present near subcutaneous tumors (49), we tested whether CCL2/CCR2 signaling was required for de novo lung tumor formation. Here, CCR2 is linked to neoplasm.